Outside the Box Cancer Therapies by Mark Stengler & Dr. Paul Anderson

Author:Mark Stengler & Dr. Paul Anderson
Language: eng
Format: epub
Publisher: Hay House
Published: 2018-03-20T04:00:00+00:00

DICHLOROACETATE (DCA)

DCA is a relatively small molecule which, in the past, was used as treatment for the metabolic disorder lactic acidosis. It inhibits lactate formation, and via a complex mechanism, switches cell metabolism away from lactic acid production (glycolytic) to mitochondrial energy metabolism (electron transport chain (ETC)).152 Noncancerous human cells prefer this aerobic pathway for energy formation via ETC use, whereas cancerous cells experience the Warburg Effect, where most glucose is converted to lactate regardless of oxygen availability.153 Forcing a cancerous cell into ETC use thereby increases damaging oxygen formation and oxygen consumption.154

Because of the differences in metabolism between most cancer cells and normal cells and through an intricate mechanism, DCA is able to cause cancer cell death via apoptosis and weaken the cancer cell in lowering its ability to proliferate. DCA also does this only in cancerous cells and not in normal cells.155 156 157

In earlier uses of DCA, it was often both overdosed and not administered with appropriate support factors. For example, DCA is both a consumer of and dependent upon (for metabolism) glutathione. Glutathione is an important detoxification molecule, and lowering its levels could slow detoxification and cause toxic side effects. The bottom line is that DCA is a potent agent in an anticancer strategy, but it must be used in very well-defined dosing parameters and always with support for the metabolic stressors it creates. While most DCA side effects are self-limited (such as dizziness and tingling in hands or feet), in earlier studies where DCA was used at high dose without any supportive therapy (for metabolism and detoxification), people did develop nerve inflammation. Dr. Anderson has administered over 10,000 doses of DCA to date with proper support therapies. He has not seen any cases of nerve inflammation, and any other side effects patients experienced were very short in duration and all resolved fully.158 159 160

Recently, many scientific papers have continued to explore the mechanisms and potentials of DCA in cancer therapies.161 162 163 164 165 Multiple human scientific studies, including drug trials and case reports,166 167 168 169 170 171 172 173 174 175 have been published with regard to DCA and several types of cancer. Currently, DCA is being tested with standard chemotherapy drugs as a synergistic agent.176 It is our belief that DCA (with proper administration and supportive therapies) is an incredible tool in the battle against cancer, and truly is unique in its actions and efficacy.

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.